Loading clinical trials...
Loading clinical trials...
Long Term Use of HPN-100 in Urea Cycle Disorders
Conditions
Interventions
HPN-100
Locations
16
United States
UCLA Pediatrics/Genetics
Los Angeles, California, United States
Stanford University School of Medicine
Palo Alto, California, United States
Denver Children's Hospital
Aurora, Colorado, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Maine Medical Center
Portland, Maine, United States
University of Minnesota Medical Center
Minneapolis, Minnesota, United States
Start Date
October 4, 2010
Primary Completion Date
February 16, 2017
Completion Date
February 16, 2017
Last Updated
August 22, 2024
NCT06805695
NCT06953505
NCT00947544
NCT00947297
NCT00992459
NCT03064048
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions